Home › Funds › Jackson Hole Capital Partners, LLC › GILD
Jackson Hole Capital Partners, LLC position in GILD
GILEAD SCIENCES INC · Health Care
Jackson Hole Capital Partners, LLC reported holding 33,305 shares of GILD (GILEAD SCIENCES INC) in its Q1 2026 13F filing — a position valued at US$4.6M, representing 0.78% of its reported portfolio and ranking #36 among its reported holdings. Jackson Hole Capital Partners, LLC has disclosed GILD holdings in 10 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Jackson Hole Capital Partners, LLC's GILD position evolved
Jackson Hole Capital Partners, LLC first disclosed a stake in GILD in Q3 2023 at 18,351 shares (US$1.4M). The position peaked in Q1 2026 at 33,305 shares, worth US$4.6M. Across 10 filings, Jackson Hole Capital Partners, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 33,305 shares valued at US$4.6M. Notable position changes include a 40% increase in Q3 2024 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 18.35K | $1.38M | New |
| Q4 2023 | 19.59K | $1.59M | Add |
| Q1 2024 | 23.10K | $1.69M | Add |
| Q3 2024 | 32.37K | $2.71M | Add |
| Q4 2024 | 34.57K | $3.19M | Add |
| Q1 2025 | 34.09K | $3.82M | Reduce |
| Q2 2025 | 34.70K | $3.85M | Add |
| Q3 2025 | 33.24K | $3.69M | Reduce |
| Q4 2025 | 33.23K | $4.08M | Hold |
| Q1 2026 | 33.30K | $4.64M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Jackson Hole Capital Partners, LLC
FAQ
How long has Jackson Hole Capital Partners, LLC held GILD?
Jackson Hole Capital Partners, LLC has disclosed GILD holdings in 10 of the last 11 reported quarters, going back to Q3 2023.
What is Jackson Hole Capital Partners, LLC's current position in GILD?
As of Q1 2026, Jackson Hole Capital Partners, LLC holds 33.30K shares of GILD (GILEAD SCIENCES INC), valued at $4.64M, representing 0.78% of its reported portfolio and ranking #36.
Has Jackson Hole Capital Partners, LLC been buying or selling GILD?
In the latest 13F filing (Q1 2026), Jackson Hole Capital Partners, LLC held unchanged its position in GILD. The position peaked in Q1 2026 at 33.30K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.